ACLX Latest News, Press Relases and Analysis

All

Press Releases

12 hours ago - By: Zacks Investment Research - Mentions: DARE

Arcellx, Inc. (ACLX) Reports Q3 Loss, Misses Revenue Estimates

13 hours ago - By: Arcellx, Inc.

Arcellx Provides Third Quarter 2025 Financial Results

3 days ago - By: Arcellx, Inc.

Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition

7 days ago - By: Zacks Investment Research - Mentions: GERN

Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

3 months ago - By: The Motley Fool

Arcellx (ACLX) Q2 Revenue Drops 72%

3 months ago - By: Benzinga

4 Analysts Assess Arcellx: What You Need To Know

2 months ago - By: Arcellx, Inc.

Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference

2 months ago - By: Yahoo Finance - Mentions: GILD

Arcellx, Inc. (ACLX) Reports 97% Response Rate in CAR-T Trial

3 months ago - By: Zacks Investment Research - Mentions: GYRE

Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates

3 months ago - By: Arcellx, Inc.

Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights

4 months ago - By: Benzinga - Mentions: GILD BMY JNJ NVS ...

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers

5 months ago - By: Investor's Business Daily - Mentions: GILD CRSP BEAM SRPT ...

The FDA Shake-Up Continues, And Could Impact Genetic Medicines

6 months ago - By: Arcellx, Inc.

Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025

6 months ago - By: Yahoo Finance - Mentions: GILD DHI CMG F

Baron Discovery Fund Initiated a Position in Arcellx (ACLX)

6 months ago - By: Arcellx, Inc.

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma

6 months ago - By: Yahoo Finance - Mentions: VZ W COIN RDNT ...

We Earned $400K Last Year With $600K Saved. How Do We Maximize Retirement Contributions on One Income?

6 months ago - By: Yahoo Finance - Mentions: GILD DHI CMG

Here’s Why Arcellx (ACLX) Declined in Q1

6 months ago - By: Zacks Investment Research - Mentions: AKYA

Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: Arcellx, Inc.

Arcellx Provides First Quarter 2025 Financial Results and Business Highlights

7 months ago - By: Yahoo Finance - Mentions: ERJ NUVL BKR META ...

Embraer announces Q1-end backlog of $26.4B

7 months ago - By: Yahoo Finance - Mentions: MSFT AAPL AAL META ...

Jim Cramer Slams Microsoft Corporation (MSFT)’s Spending: ‘$80 Billion Isn’t Enough, Partner’

7 months ago - By: Yahoo Finance - Mentions: ADMA META ERJ NUVL ...

ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying

7 months ago - By: Yahoo Finance - Mentions: HSY META ERJ ADMA ...

The Hershey Company (HSY): Among Takeover Rumors Hedge Funds Are Buying

7 months ago - By: Yahoo Finance - Mentions: BP NUVL ERJ DHI ...

BP p.l.c. (BP): Among Takeover Rumors Hedge Funds Are Buying

7 months ago - By: Yahoo Finance - Mentions: NUVL ALAB ERJ AXP ...

Nuvalent, Inc. (NUVL): Among Takeover Rumors Hedge Funds Are Buying

7 months ago - By: Yahoo Finance - Mentions: DAKT C APP OXY

Daktronics, Inc. (DAKT): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

7 months ago - By: Yahoo Finance - Mentions: DAKT COMP OXY TSLA

Arcellx (ACLX): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

7 months ago - By: Yahoo Finance - Mentions: PCT DAKT QCOM THTX ...

PureCycle Technologies (PCT): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

8 months ago - By: Arcellx, Inc.

ARCELLX INC (ACLX) Stock News

ACLX Latest News, Press Relases and Analysis

Arcellx, Inc. (ACLX) Reports Q3 Loss, Misses Revenue Estimates

Arcellx Provides Third Quarter 2025 Financial Results

Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition

Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Arcellx (ACLX) Q2 Revenue Drops 72%

4 Analysts Assess Arcellx: What You Need To Know

Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference

Arcellx, Inc. (ACLX) Reports 97% Response Rate in CAR-T Trial

Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates

Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers

The FDA Shake-Up Continues, And Could Impact Genetic Medicines

Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025

Baron Discovery Fund Initiated a Position in Arcellx (ACLX)

Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma

We Earned $400K Last Year With $600K Saved. How Do We Maximize Retirement Contributions on One Income?

Here’s Why Arcellx (ACLX) Declined in Q1

Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates

Arcellx Provides First Quarter 2025 Financial Results and Business Highlights

Embraer announces Q1-end backlog of $26.4B

Jim Cramer Slams Microsoft Corporation (MSFT)’s Spending: ‘$80 Billion Isn’t Enough, Partner’

ADMA Biologics, Inc. (ADMA): Among Takeover Rumors Hedge Funds Are Buying

The Hershey Company (HSY): Among Takeover Rumors Hedge Funds Are Buying

BP p.l.c. (BP): Among Takeover Rumors Hedge Funds Are Buying

Nuvalent, Inc. (NUVL): Among Takeover Rumors Hedge Funds Are Buying

Daktronics, Inc. (DAKT): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

Arcellx (ACLX): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

PureCycle Technologies (PCT): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors